Cabaletta Bio Insider Surge: Execs Buy 22,000 Option Shares Amid 554 % Social Media Frenzy, Betting on 12‑Month Pipeline Gains
Insider confidence spikes at Cabaletta Bio: Shawn Tomasello’s new 22k option block shows executives betting on a 12‑month T‑cell therapy push—watch for a price rally.
3 minutes to read